Frequently Asked Questions about the Noom subscription What does a Noom subscription include
A patient may be a candidate for GLP-1 weight loss if they have obesity, overweight with weight-related health concerns, insulin resistance, prediabetes, type 2 diabetes risk, high blood pressure, high cholesterol, fatty liver concerns, sleep apnea risk, or repeated difficulty losing and maintaining weight with lifestyle changes alone
Half of our members with coverage pay $50/month or less copay.* We make it simple: Submit your insurance card, and well take care of the rest
One of the ways we do that is by being transparent about what is in the medications customers are sent, which is why customers can find a Certificate of Analysis in every order
This article examines the evidence for blood pressure reduction with GLP-1 therapy, identifies which patients may benefit most from this additional effect, and outlines important safety considerations
As a triple agonist targeting GLP-1, GIP, and glucagon receptors, it engages even more pathways than tirzepatide